Champions Oncology
CSBR
CSBR
23 hedge funds and large institutions have $29.9M invested in Champions Oncology in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% less funds holding
Funds holding: 25 → 23 (-2)
73% less call options, than puts
Call options by funds: $17K | Put options by funds: $63K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
23
Holding in Top 10
1
Calls
$17K
Puts
$63K
Top Buyers
| 1 | +$1.14M | |
| 2 | +$12.4K | |
| 3 | +$7.03K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.03K |
| 5 |
BlackRock
New York
|
+$2.01K |
Top Sellers
| 1 | -$378K | |
| 2 | -$13.5K | |
| 3 | -$11.5K | |
| 4 |
Renaissance Technologies
New York
|
-$10.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.76K |